MaxLinear, Inc. 10-Q Summary
Business Context and Reporting Period
MaxLinear is a fabless semiconductor company that designs radio-frequency and mixed-signal integrated circuits for broadband communications, including cable modems, gateways, set-top boxes and digital televisions. This unaudited Form 10-Q covers the three and nine months ended September 30, 2013, compared with the corresponding 2012 periods.
Financial Results and Key Metrics
| Metric | Q3 2013 | Q3 2012 | 9M 2013 | 9M 2012 |
|---|---|---|---|---|
| Net revenue | $31.8 million | $27.8 million | $88.1 million | $72.9 million |
| Gross profit | $19.8 million | $17.5 million | $53.8 million | $44.9 million |
| Gross margin | 62% | 63% | 61% | 62% |
| Operating income (loss) | $(4.7) million | $0.4 million | $(9.7) million | $(8.6) million |
| Net income (loss) | $(4.9) million | $0.5 million | $(10.1) million | $(8.7) million |
| Diluted EPS | $(0.14) | $0.01 | $(0.30) | $(0.26) |
- Revenue increased 14% year over year in Q3 and 21% for the first nine months. Cable revenue rose 25% in Q3 and 33% year to date, while terrestrial revenue declined 5% in Q3 and increased 1% year to date.
- Q3 gross profit increased 14%, but gross margin declined one percentage point because average selling prices for certain products declined faster than manufacturing costs. The nine-month margin also reflected a $1.1 million impairment of production masks.
- Research and development expense increased 34% in Q3 to $14.6 million and 14% year to date to $38.4 million. Selling, general and administrative expense increased 62% in Q3 to $10.0 million and 27% year to date to $25.1 million.
- Operating results included $9.6 million of stock-based compensation during the first nine months, compared with $7.2 million in the prior-year period.
- Net cash provided by operating activities was $10.1 million for the first nine months, compared with $6.2 million in 2012. Investing cash flow was $(5.4) million, and financing cash flow was approximately $(0.02) million.
- Cash and cash equivalents were $26.5 million at September 30, 2013. Short- and long-term investments totaled $56.5 million, producing total cash, cash equivalents and investments of $83.0 million, compared with $77.3 million at December 31, 2012.
- Working capital was $58.0 million, down from $68.5 million at December 31, 2012. Net accounts receivable were $18.9 million and inventory was $9.7 million.
- The filing reports no material debt; capital lease obligations were substantially completed during the first nine months. Management stated that available cash and investments should fund projected operating requirements for at least the next twelve months, although additional capital or indebtedness may be required in the future.
Material Changes Versus the Prior Comparable Period
- Revenue growth was driven primarily by DOCSIS 3.0 cable modem and video server-gateway applications. Cable products represented 70% of Q3 revenue and 69% of nine-month revenue, versus 64% and 63%, respectively, in the comparable 2012 periods.
- The company moved from a small operating profit in Q3 2012 to an operating loss in Q3 2013, primarily because operating expenses grew faster than gross profit.
- SG&A included a $1.25 million one-time payment related to the settlement of Silicon Laboratories patent litigation, as well as higher legal and payroll costs.
- Cash increased despite the net loss, aided by $10.1 million of operating cash flow and the settlement of 2012 employee bonuses with approximately 0.8 million shares of Class A common stock rather than cash.
- The accrued price-protection liability increased to $12.5 million from $7.9 million at December 31, 2012. Price-protection charges reduced revenue by $15.9 million during the first nine months.
Outlook, Commentary, Risks and Unusual Items
- Management expects research and development expense to increase as it expands its product portfolio and develops new platforms. SG&A is also expected to increase as sales, marketing and international administrative capabilities expand.
- Gross margin is expected to fluctuate with product mix, average selling prices and manufacturing costs. The company faces ongoing average-selling-price erosion and competitive pricing pressure.
- Management expects cable and terrestrial revenue contribution trends to remain relatively consistent for the remainder of 2013, but the filing does not provide specific numerical revenue or earnings guidance.
- All outstanding Silicon Laboratories patent litigation was settled. The parties dismissed the litigation, granted each other limited worldwide royalty-free licenses for existing products subject to the litigation, released past infringement claims, and agreed not to bring patent infringement lawsuits against each other for three years.
- Key operating risks include customer concentration, reliance on purchase orders rather than long-term commitments, distributor inventory and price-protection obligations, semiconductor cyclicality, product obsolescence, lengthy design-win and qualification cycles, and dependence on third-party Asian foundries and assembly/test providers.
- One customer represented 27% of Q3 revenue and 29% of nine-month revenue; the ten largest customers represented 71% and 73%, respectively. Products shipped to Asia represented 94% of Q3 revenue and 93% of nine-month revenue.
- The company maintains a valuation allowance against U.S. federal and California deferred tax assets. It is under IRS examination for tax years 2010 and 2011, and management does not expect significant changes in unrecognized tax benefits over the next twelve months.
- Management concluded that disclosure controls and procedures were effective as of September 30, 2013, with no material change in internal control over financial reporting during the quarter.
Important Facts for Investors to Verify
- Whether cable-product growth and DOCSIS-related demand offset terrestrial-market weakness and customer concentration risk.
- Whether gross margins stabilize despite average-selling-price declines, product mix changes and manufacturing-cost pressure.
- The sustainability of positive operating cash flow while the company reports recurring net losses and rising research and development spending.
- The adequacy and liquidity of the $83.0 million cash and investment portfolio relative to future operating, litigation, product-development and capital requirements.
- The accuracy of accrued price-protection, distributor-related deferred profit and inventory estimates.
- The business impact of the Silicon Laboratories settlement, including the scope of the cross-licenses and the three-year litigation standstill.
- Exposure to major customers, Asian end markets, distributors and third-party manufacturing, assembly and testing capacity.